ENDRA Life Sciences NDRA

€ 3.82 5.46%

Quartalsbericht 2024-Q2
hinzugefügt 14.08.2024

Andere Aktien der Branche "Diagnostik & Forschung"

Name	Preis	% 24h	Marktkapitalisierung	Börse	Land
Centogene N.V. CNTG	$ 0.33	-6.23 %	$ 30.6 M	Nasdaq Global Market	Germany
Fluidigm Corporation FLDM	$ 3.75	1.08 %	$ 308 M	Nasdaq Global Select Market	USA
Global Cord Blood Corporation CO	$ 2.99	-	$ 399 M	NYSE	China
Oxford Immunotec Global PLC OXFD	$ 21.99	-	$ 562 M	Nasdaq Global Select Market	Britain
Genetron Holdings Limited GTH	$ 4.03	0.12 %	$ 80.1 M	Nasdaq Global Market	China
Chembio Diagnostics CEMI	$ 0.46	0.22 %	$ 16.8 M	Nasdaq Capital Market	USA
Meridian Bioscience VIVO	$ 33.97	-	$ 1.49 B	Nasdaq Global Select Market	USA
HTG Molecular Diagnostics HTGM	$ 0.48	-20.0 %	$ 1.06 M	Nasdaq Capital Market	USA
Quotient Limited QTNT	$ 0.32	-11.32 %	$ 1.1 M	Nasdaq Global Select Market	Schweiz
Aspira Women's Health AWH	$ 0.11	-4.49 %	$ 12.8 M	Nasdaq Capital Market,SPB	USA
PRA Health Sciences, Inc. PRAH	$ 165.21	-	$ 10.7 B	Nasdaq Global Select Market	USA
Heska Corporation HSKA	$ 119.99	-	$ 1.31 B	Nasdaq Capital Market,SPB	USA
Charles River Laboratories International CRL	$ 168.71	-2.97 %	$ 8.67 B	NYSE,SPB	USA
Burning Rock Biotech Limited BNR	$ 5.84	6.18 %	$ 59.9 M	Nasdaq Global Market	China
Motus GI Holdings MOTS	$ 0.17	-34.28 %	$ 263 K	Nasdaq Global Select Market	Israel
Biocept BIOC	$ 0.43	-13.05 %	$ 7.29 M	Nasdaq Capital Market	USA
PerkinElmer PKI	$ 115.24	-0.91 %	$ 14.7 B	NYSE,SPB	USA
Syneos Health SYNH	$ 42.98	-	$ 4.46 B	Nasdaq Global Select Market,SPB	USA
Fulgent Genetics FLGT	$ 17.09	1.3 %	$ 517 M	Nasdaq Global Market	USA
Invitae Corporation NVTA	$ 0.09	-	$ 21.2 M	NYSE,SPB	USA